The FDA’s Peptide Crossroads: Will Regulation Clean Up the Gray Market—or Drive It Deeper Underground?
In this Deep Dive, Dr. Mike Belkowski examines the darker side of the rapidly growing peptide movement: unregulated sourcing, research-use-only products, online dosing communities, peptide stacking, questionable testing, and the widening gap between consumer experimentation and medical oversight.
The episode begins with a recent review exploring how the success of GLP-1 drugs helped normalize self-injection and created an “Ozempic halo” around experimental peptides. Dr. Mike breaks down the digital peptide exposure pathway, the legal fiction of research-use-only labels, the risks of informal…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.